InvestorsHub Logo

Gnyce3

10/17/14 3:32 PM

#75161 RE: Jmasdoc #75160

Absolutely. We've all seen this stock soar on the mere speculation of an article or positive piece of news. To end the day red on TLD publication seems like something from the twilight zone. I've still got my shares as well, but I can't justify holding them much longer. I wish there was a definitive answer as to why things are as they are. There is a lot of talk about market manipulation, but I find it hard to believe that given such ground breaking results from the ONLY HESC trial ever performed (aside from GERN) that the shorts can really control it that sharply. If it was gonna fly it should have...

elysse1kittycat

10/17/14 3:41 PM

#75163 RE: Jmasdoc #75160

When the stock price is CONTROLLED by the self-serving mm's, naked shorters along with such concurrent forces as collusion and rampant manipulation, etc., trying to use sheer logic as to why the stock price isn't commensurate with the very exciting and promising news and developments we have seen and heard of late, makes about as much sense as trying to figure out/handicap in advance who will "win" a pro wrestling match if you catch my drift.
Having owned this stock for over eight years and having a sizeable positon, imo lets just kindly say that supply and demand learned in Economic 101 are not "quite" what determines the daily fluctuations in the stockprice.

lasers

10/20/14 8:54 AM

#75209 RE: Jmasdoc #75160

Jmasdoc

"FDA for compassionate care treatment" is exactly what $ACTC should be pursuing for "early approval" with a Pivotal Phase2B.